Seeking Alpha

Pharmasset (VRUS +7.3%) trades higher after announcing it's expanding electron trials of its...

Pharmasset (VRUS +7.3%) trades higher after announcing it's expanding electron trials of its hepatitis C drug treatment after tests showed positive results at a higher dose when combined with other treatments.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|